Beltran-Alvarez Pedro, Feixas Ferran, Osuna Sílvia, Díaz-Hernández Rubí, Brugada Ramon, Pagans Sara
Cardiovascular Genetics Center, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, University of Girona, 17003, Girona, Spain,
Amino Acids. 2015 Feb;47(2):429-34. doi: 10.1007/s00726-014-1890-0. Epub 2014 Dec 16.
Arginine methylation is a novel post-translational modification within the voltage-gated ion channel superfamily, including the cardiac sodium channel, NaV1.5. We show that NaV1.5 R513 methylation decreases S516 phosphorylation rate by 4 orders of magnitude, the first evidence of protein kinase A inhibition by arginine methylation. Reciprocally, S516 phosphorylation blocks R513 methylation. NaV1.5 p.G514C, associated to cardiac conduction disease, abrogates R513 methylation, while leaving S516 phosphorylation rate unchanged. This is the first report of methylation-phosphorylation cross-talk of a cardiac ion channel.
精氨酸甲基化是电压门控离子通道超家族(包括心脏钠通道NaV1.5)内一种新型的翻译后修饰。我们发现,NaV1.5的R513甲基化使S516磷酸化速率降低了4个数量级,这是精氨酸甲基化抑制蛋白激酶A的首个证据。相反,S516磷酸化会阻断R513甲基化。与心脏传导疾病相关的NaV1.5 p.G514C消除了R513甲基化,而S516磷酸化速率保持不变。这是关于心脏离子通道甲基化 - 磷酸化相互作用的首次报道。